This website provides information on patients with mutations in the KCNQ3 gene, including clinical data, molecular data, management, and research options.

KCNQ3-related disorders are caused by pathogenic variants in the KCNQ3 gene and are mainly characterised by neonatal or infantile seizures with or without developmental delay.

This website was created to share and collect information about clinic, management and research projects to gather more knowledge and provide better treatment of patients with mutations in the KCNQ3 gene.

Sarah Weckhuysen, MD, PhD, Applied & Translational Neurogenomics Group, VIB Center for Molecular Neurology, VIB, Dept. of Neurology, University Hospital µNEURO Research Centre of Excellence, University of Antwerp, Antwerp, Belgium. Translational Neurosciences, Faculty of Medicine and Health Science, University of Antwerp, Sarah.weckhuysen@uantwerpen.vib.be

Maurizio Taglialatela, MD, PhD, Dept. of Neuroscience, University of Naples Federico II, Naples, Italy, maurizio.taglialatela@unina.it